Page last updated: 2024-10-21

1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one and Cancer of Prostate

1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one has been researched along with Cancer of Prostate in 1 studies

1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one: structure given in first source; inhibits guanylyl cyclase
1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one : A member of the class of oxadiazoloquinoxalines that is 1H-[1,2,4]oxadiazolo[4,3-a]quinoxaline substituted at position 1 by an oxo group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jongsma, J1
Oomen, MH1
Noordzij, MA1
Romijn, JC1
van Der Kwast, TH1
Schröder, FH1
van Steenbrugge, GJ1

Other Studies

1 other study available for 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one and Cancer of Prostate

ArticleYear
Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines.
    The Prostate, 2000, Volume: 42, Issue:1

    Topics: Androgens; Cell Division; Cyclic AMP; Dideoxyadenosine; Enzyme Inhibitors; Gastrin-Releasing Peptide

2000